<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26606652</PMID><DateCompleted><Year>2016</Year><Month>08</Month><Day>15</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2326-5205</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>4</Issue><PubDate><Year>2016</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Arthritis &amp; rheumatology (Hoboken, N.J.)</Title><ISOAbbreviation>Arthritis Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Genome-Wide Association Study in an Amerindian Ancestry Population Reveals Novel Systemic Lupus Erythematosus Risk Loci and the Role of European Admixture.</ArticleTitle><Pagination><StartPage>932</StartPage><EndPage>943</EndPage><MedlinePgn>932-43</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/art.39504</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with a strong genetic component. We undertook the present work to perform the first genome-wide association study on individuals from the Americas who are enriched for Native American heritage.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We analyzed 3,710 individuals from the US and 4 countries of Latin America who were diagnosed as having SLE, and healthy controls. Samples were genotyped with HumanOmni1 BeadChip. Data on out-of-study controls genotyped with HumanOmni2.5 were also included. Statistical analyses were performed using SNPtest and SNPGWA. Data were adjusted for genomic control and false discovery rate. Imputation was performed using Impute2 and, for classic HLA alleles, HiBag. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The IRF5-TNPO3 region showed the strongest association and largest OR for SLE (rs10488631: genomic control-adjusted P [Pgcadj ] = 2.61 &#xd7; 10(-29), OR 2.12 [95% CI 1.88-2.39]), followed by HLA class II on the DQA2-DQB1 loci (rs9275572: Pgcadj &#x2009;=&#x2009;1.11 &#xd7; 10(-16), OR 1.62 [95% CI 1.46-1.80] and rs9271366: Pgcadj &#x2009;=&#x2009;6.46 &#xd7; 10(-12), OR 2.06 [95% CI 1.71-2.50]). Other known SLE loci found to be associated in this population were ITGAM, STAT4, TNIP1, NCF2, and IRAK1. We identified a novel locus on 10q24.33 (rs4917385: Pgcadj &#x2009;=&#x2009;1.39 &#xd7; 10(-8)) with an expression quantitative trait locus (eQTL) effect (Peqtl &#x2009;=&#x2009;8.0 &#xd7; 10(-37) at USMG5/miR1307), and several new suggestive loci. SLE risk loci previously identified in Europeans and Asians were corroborated. Local ancestry estimation showed that the HLA allele risk contribution is of European ancestral origin. Imputation of HLA alleles suggested that autochthonous Native American haplotypes provide protection against development of SLE.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our results demonstrate that studying admixed populations provides new insights in the delineation of the genetic architecture that underlies autoimmune and complex diseases.</AbstractText><CopyrightInformation>&#xa9; 2016, American College of Rheumatology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alarc&#xf3;n-Riquelme</LastName><ForeName>Marta E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Oklahoma Medical Research Foundation, Oklahoma City.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziegler</LastName><ForeName>Julie T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Wake Forest School of Medicine, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molineros</LastName><ForeName>Julio</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Oklahoma Medical Research Foundation, Oklahoma City.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howard</LastName><ForeName>Timothy D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Wake Forest School of Medicine, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno-Estrada</LastName><ForeName>Andr&#xe9;s</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Stanford University School of Medicine, Stanford, California, and Laboratorio Nacional de Gen&#xf3;mica para la Biodiversidad, Centro de Investigaci&#xf3;n y de Estudios Avanzados del Instituto Polit&#xe9;cnico Nacional, Irapuato, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-Rodr&#xed;guez</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Icahn School of Medicine at Mount Sinai, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ainsworth</LastName><ForeName>Hannah C</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Wake Forest School of Medicine, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortiz-Tello</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Stanford University School of Medicine, Stanford, California, and Laboratorio Nacional de Gen&#xf3;mica para la Biodiversidad, Centro de Investigaci&#xf3;n y de Estudios Avanzados del Instituto Polit&#xe9;cnico Nacional, Irapuato, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Comeau</LastName><ForeName>Mary E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Wake Forest School of Medicine, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasmussen</LastName><ForeName>Astrid</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Oklahoma Medical Research Foundation, Oklahoma City.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kelly</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Oklahoma Medical Research Foundation, Oklahoma City.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adler</LastName><ForeName>Adam</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Oklahoma Medical Research Foundation, Oklahoma City.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Acevedo-V&#xe1;zquez</LastName><ForeName>Eduardo M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cucho-Venegas</LastName><ForeName>Jorge Mariano</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-De la Torre</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Hospital General de Occidente, Zapopan, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cardiel</LastName><ForeName>Mario H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Cl&#xed;nica de Morelia, Morelia, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miranda</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Centro de Estudios Reumatol&#xf3;gicos, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Catoggio</LastName><ForeName>Luis J</ForeName><Initials>LJ</Initials><AffiliationInfo><Affiliation>Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maradiaga-Cece&#xf1;a</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital General de Culiac&#xe1;n, Culiac&#xe1;n, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gaffney</LastName><ForeName>Patrick M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Oklahoma Medical Research Foundation, Oklahoma City.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vyse</LastName><ForeName>Timothy J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Criswell</LastName><ForeName>Lindsey A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>University of California, San Francisco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsao</LastName><ForeName>Betty P</ForeName><Initials>BP</Initials><AffiliationInfo><Affiliation>University of California, Los Angeles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivils</LastName><ForeName>Kathy L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Oklahoma Medical Research Foundation, Oklahoma City.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bae</LastName><ForeName>Sang-Cheol</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>James</LastName><ForeName>Judith A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Oklahoma Medical Research Foundation and University of Oklahoma Health Sciences Center, Oklahoma City.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kimberly</LastName><ForeName>Robert P</ForeName><Initials>RP</Initials><AffiliationInfo><Affiliation>University of Alabama at Birmingham.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaufman</LastName><ForeName>Kenneth M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harley</LastName><ForeName>John B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esquivel-Valerio</LastName><ForeName>Jorge A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Hospital Universitario Dr. Jos&#xe9; Eleuterio Gonz&#xe1;lez Universidad Autonoma de Nuevo Le&#xf3;n, Monterrey, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moctezuma</LastName><ForeName>Jos&#xe9; F</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Hospital General de M&#xe9;xico, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a</LastName><ForeName>Mercedes A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Hospital Interzonal General de Agudos General San Martin, La Plata, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berbotto</LastName><ForeName>Guillermo A</ForeName><Initials>GA</Initials><AffiliationInfo><Affiliation>Hospital Escuela Eva Per&#xf3;n, Granadero Baigorria, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Babini</LastName><ForeName>Alejandra M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Hospital Italiano de C&#xf3;rdoba, C&#xf3;rdoba, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scherbarth</LastName><ForeName>Hugo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Hospital Interzonal General de Agudos Oscar E. Alende, Mar del Plata, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toloza</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital Interzonal San Juan Bautista, San Fernando del Valle de Catamarca, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baca</LastName><ForeName>Vicente</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Hospital de Peditaria, Centro M&#xe9;dico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nath</LastName><ForeName>Swapan K</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>Oklahoma Medical Research Foundation, Oklahoma City.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguilar Salinas</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Orozco</LastName><ForeName>Lorena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Medicina Gen&#xf3;mica, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tusi&#xe9;-Luna</LastName><ForeName>Teresa</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n and Instituto de Investigaciones Biom&#xe9;dicas de la Universidad Nacional Aut&#xf3;noma de M&#xe9;xico, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zidovetzki</LastName><ForeName>Raphael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>University of California, Riverside.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pons-Estel</LastName><ForeName>Bernardo A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Sanatorio Parque, Rosario, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langefeld</LastName><ForeName>Carl D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Wake Forest School of Medicine, Winston-Salem, North Carolina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacob</LastName><ForeName>Chaim O</ForeName><Initials>CO</Initials><AffiliationInfo><Affiliation>University of Southern California School of Medicine, Los Angeles.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30-GM-103510</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P60 AR053308</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54 GM104938</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01-A101934</GrantID><Agency>PHS HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI082714</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 GM103510</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AR065626</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI107176</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01-AR-043814</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21-AR-065626</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AR053483</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01-CA-141700</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21-AI-107176</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RC1 AR058621</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 GM110766</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01-AR-060366</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR043814</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR057172</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AI101934</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI024717</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR060366</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01-AR-049084</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA141700</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001417</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30-AR-053483</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AI083194</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RC1-AR-058621</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AR049084</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01-AR-057172</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19-A1082714</GrantID><Agency>PHS HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U54-GM-104938</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01-AI-083194</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Arthritis Rheumatol</MedlineTA><NlmUniqueID>101623795</NlmUniqueID><ISSNLinking>2326-5191</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000606721">ATP5MK protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D039481">CD11b Antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006683">HLA-DQ Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059866">HLA-DQ beta-Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C103596">HLA-DQA2 antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C069051">HLA-DQB1 antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C431713">IRF5 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C509295">ITGAM protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050835">Interferon Regulatory Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050797">STAT4 Transcription Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C494090">STAT4 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C117046">TNIP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C546476">TNPO3 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D028961">beta Karyopherins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.6.3.-</RegistryNumber><NameOfSubstance UI="D019255">NADPH Oxidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.6.3.1</RegistryNumber><NameOfSubstance UI="C527764">NCF2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C507768">IRAK1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D053592">Interleukin-1 Receptor-Associated Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.3.-</RegistryNumber><NameOfSubstance UI="D025261">Mitochondrial Proton-Translocating ATPases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D044467" MajorTopicYN="N">American Indian or Alaska Native</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001118" MajorTopicYN="N" Type="Geographic">Argentina</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D039481" MajorTopicYN="N">CD11b Antigen</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002677" MajorTopicYN="N" Type="Geographic">Chile</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002879" MajorTopicYN="N">Chromosomes, Human, Pair 10</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006683" MajorTopicYN="N">HLA-DQ Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059866" MajorTopicYN="N">HLA-DQ beta-Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006239" MajorTopicYN="N">Haplotypes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050835" MajorTopicYN="N">Interferon Regulatory Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053592" MajorTopicYN="N">Interleukin-1 Receptor-Associated Kinases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008800" MajorTopicYN="N" Type="Geographic">Mexico</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025261" MajorTopicYN="N">Mitochondrial Proton-Translocating ATPases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019255" MajorTopicYN="N">NADPH Oxidases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010568" MajorTopicYN="N" Type="Geographic">Peru</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025341" MajorTopicYN="N">Principal Component Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D050797" MajorTopicYN="N">STAT4 Transcription Factor</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044465" MajorTopicYN="N">White People</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D028961" MajorTopicYN="N">beta Karyopherins</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Conflicts of Interest</b>. The authors declare no conflicts of interest</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2015</Year><Month>11</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>11</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2016</Year><Month>8</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">26606652</ArticleId><ArticleId IdType="mid">NIHMS774837</ArticleId><ArticleId IdType="pmc">PMC4829354</ArticleId><ArticleId IdType="doi">10.1002/art.39504</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pons-Estel BA, Catoggio LJ, Cardiel MH, Soriano ER, Gentiletti S, Villa AR, Abadi I, Caeiro F, Alvarellos A, Alarcon-Segovia D. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among &#x201c;Hispanics&#x201d;. Medicine (Baltimore) 2004;83:1&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">14747764</ArticleId></ArticleIdList></Reference><Reference><Citation>Auton A, Bryc K, Boyko AR, Lohmueller KE, Novembre J, Reynolds A, Indap A, Wright MH, Degenhardt JD, Gutenkunst RN, et al. Global distribution of genomic diversity underscores rich complex history of continental human populations. Genome research. 2009;19:795&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2675968</ArticleId><ArticleId IdType="pubmed">19218534</ArticleId></ArticleIdList></Reference><Reference><Citation>Harley JB, Alarcon-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL, Tsao BP, Vyse TJ, Langefeld CD. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet. 2008;40:204&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3712260</ArticleId><ArticleId IdType="pubmed">18204446</ArticleId></ArticleIdList></Reference><Reference><Citation>Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S, Lee AT, Chung SA, Ferreira RC, Pant PV, et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med. 2008;358:900&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pubmed">18204098</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo-Alen J, Reveille JD, Rodriguez-Valverde V, McGwin G, Jr, Baethge BA, Friedman AW, Alarcon GS. Clinical, immunogenetic and outcome features of Hispanic systemic lupus erythematosus patients of different ethnic ancestry. Lupus. 2003;12:377&#x2013;385.</Citation><ArticleIdList><ArticleId IdType="pubmed">12765301</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez E, Rasmussen A, Riba L, Acevedo-Vasquez E, Kelly JA, Langefeld CD, Williams AH, Ziegler JT, Comeau ME, Marion MC, et al. Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations. Arthritis and Rheumatism. 2012;64:3687&#x2013;3694.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3485439</ArticleId><ArticleId IdType="pubmed">22886787</ArticleId></ArticleIdList></Reference><Reference><Citation>Richman IB, Taylor KE, Chung SA, Trupin L, Petri M, Yelin E, Graham RR, Lee A, Behrens TW, Gregersen PK, et al. European genetic ancestry is associated with a decreased risk of lupus nephritis. Arthritis and Rheumatism. 2012;64:3374&#x2013;3382.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3865923</ArticleId><ArticleId IdType="pubmed">23023776</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez E, Webb RD, Rasmussen A, Kelly JA, Riba L, Kaufman KM, Garcia-de la Torre I, Moctezuma JF, Maradiaga-Cecena MA, Cardiel-Rios MH, et al. Genetically determined Amerindian ancestry correlates with increased frequency of risk alleles for systemic lupus erythematosus. Arthritis and Rheumatism. 2010;62:3722&#x2013;3729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3078084</ArticleId><ArticleId IdType="pubmed">20848568</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271&#x2013;1277.</Citation><ArticleIdList><ArticleId IdType="pubmed">7138600</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchez E, Nadig A, Richardson BC, Freedman BI, Kaufman KM, Kelly JA, Niewold TB, Kamen DL, Gilkeson GS, Ziegler JT, et al. Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus. Annals of the rheumatic diseases. 2011;70:1752&#x2013;1757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3232181</ArticleId><ArticleId IdType="pubmed">21719445</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez M, Clark RM, Nath SK, Bhatti S, Sharma R, Alonso E, Rasmussen A, Bidichandani SI. Genetic admixture of European FRDA genes is the cause of Friedreich ataxia in the Mexican population. Genomics. 2004;84:779&#x2013;784.</Citation><ArticleIdList><ArticleId IdType="pubmed">15475256</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Ray N, Rojas W, Parra MV, Bedoya G, Gallo C, Poletti G, Mazzotti G, Hill K, Hurtado AM, et al. Geographic patterns of genome admixture in Latin American Mestizos. PLoS Genet. 2008;4:e1000037.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2265669</ArticleId><ArticleId IdType="pubmed">18369456</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams AL, Jacobs SB, Moreno-Macias H, Huerta-Chagoya A, Churchhouse C, Marquez-Luna C, Garcia-Ortiz H, Gomez-Vazquez MJ, Burtt NP, Aguilar-Salinas CA, et al. Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature. 2014;506:97&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4127086</ArticleId><ArticleId IdType="pubmed">24390345</ArticleId></ArticleIdList></Reference><Reference><Citation>Manichaikul A, Mychaleckyj JC, Rich SS, Daly K, Sale M, Chen WM. Robust relationship inference in genome-wide association studies. Bioinformatics. 2010;26:2867&#x2013;2873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3025716</ArticleId><ArticleId IdType="pubmed">20926424</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander DH, Novembre J, Lange K. Fast model-based estimation of ancestry in unrelated individuals. Genome research. 2009;19:1655&#x2013;1664.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2752134</ArticleId><ArticleId IdType="pubmed">19648217</ArticleId></ArticleIdList></Reference><Reference><Citation>Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26:2190&#x2013;2191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2922887</ArticleId><ArticleId IdType="pubmed">20616382</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X, Stephens M. Genome-wide efficient mixed-model analysis for association studies. Nat Genet. 2012;44:821&#x2013;824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3386377</ArticleId><ArticleId IdType="pubmed">22706312</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright SP. Adjusted P-values for Simultaneous Inference. Biometrics. 1992;48:1005&#x2013;1013.</Citation></Reference><Reference><Citation>Hancock DB, Levy JL, Gaddis NC, Bierut LJ, Saccone NL, Page GP, Johnson EO. Assessment of genotype imputation performance using 1000 Genomes in African American studies. PLoS ONE. 2012;7:e50610.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3511547</ArticleId><ArticleId IdType="pubmed">23226329</ArticleId></ArticleIdList></Reference><Reference><Citation>Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nature Genetics. 2012;44:955&#x2013;959.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3696580</ArticleId><ArticleId IdType="pubmed">22820512</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng X, Shen J, Cox C, Wakefield JC, Ehm MG, Nelson MR, Weir BS. HIBAG-HLA genotype imputation with attribute bagging. The pharmacogenomics journal. 2014;14:192&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3772955</ArticleId><ArticleId IdType="pubmed">23712092</ArticleId></ArticleIdList></Reference><Reference><Citation>Brisbin A, Bryc K, Byrnes J, Zakharia F, Omberg L, Degenhardt J, Reynolds A, Ostrer H, Mezey JG, Bustamante CD. PCAdmix: principal components-based assignment of ancestry along each chromosome in individuals with admixed ancestry from two or more populations. Human biology. 2012;84:343&#x2013;364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3740525</ArticleId><ArticleId IdType="pubmed">23249312</ArticleId></ArticleIdList></Reference><Reference><Citation>The International HapMap Project. Nature. 2003;426:789&#x2013;796.</Citation><ArticleIdList><ArticleId IdType="pubmed">14685227</ArticleId></ArticleIdList></Reference><Reference><Citation>Altshuler DM, Gibbs RA, Peltonen L, Dermitzakis E, Schaffner SF, Yu F, Bonnen PE, de Bakker PI, Deloukas P, Gabriel SB, et al. Integrating common and rare genetic variation in diverse human populations. Nature. 2010;467:52&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3173859</ArticleId><ArticleId IdType="pubmed">20811451</ArticleId></ArticleIdList></Reference><Reference><Citation>Browning SR, Browning BL. Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet. 2007;81:1084&#x2013;1097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2265661</ArticleId><ArticleId IdType="pubmed">17924348</ArticleId></ArticleIdList></Reference><Reference><Citation>Kidd JM, Gravel S, Byrnes J, Moreno-Estrada A, Musharoff S, Bryc K, Degenhardt JD, Brisbin A, Sheth V, Chen R, et al. Population genetic inference from personal genome data: impact of ancestry and admixture on human genomic variation. American Journal of Human Genetics. 2012;91:660&#x2013;671.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3484644</ArticleId><ArticleId IdType="pubmed">23040495</ArticleId></ArticleIdList></Reference><Reference><Citation>Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature 2013</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4127086</ArticleId><ArticleId IdType="pubmed">24390345</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH, Jung SH, Bae JS, Lee HS, Yim SH, Park SY, Bang SY, Hu HJ, Shin HD, Bae SC, et al. Deletion variants of RABGAP1L, 10q21.3, and C4 are associated with the risk of systemic lupus erythematosus in Korean women. Arthritis and Rheumatism. 2013;65:1055&#x2013;1063.</Citation><ArticleIdList><ArticleId IdType="pubmed">23335107</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu JY, Pfuhl T, Motsch N, Barth S, Nicholls J, Grasser F, Meister G. Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J Virol. 2009;83:3333&#x2013;3341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2655542</ArticleId><ArticleId IdType="pubmed">19144710</ArticleId></ArticleIdList></Reference><Reference><Citation>Stranger BE, Montgomery SB, Dimas AS, Parts L, Stegle O, Ingle CE, Sekowska M, Smith GD, Evans D, Gutierrez-Arcelus M, et al. Patterns of cis regulatory variation in diverse human populations. PLoS genetics. 2012;8:e1002639.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3330104</ArticleId><ArticleId IdType="pubmed">22532805</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernando MMA, Goyettem P, Oksenberg J, Behrens T, Hauser SL, Rioux JD, Vyse TJ. Dissecting the MHC contribution to SLE. Ann Rheum Dis. 2008;67:113.</Citation></Reference><Reference><Citation>Zuniga J, Yu N, Barquera R, Alosco S, Ohashi M, Lebedeva T, Acuna-Alonzo V, Yunis M, Granados-Montiel J, Cruz-Lagunas A, et al. HLA class I and class II conserved extended haplotypes and their fragments or blocks in Mexicans: implications for the study of genetic diversity in admixed populations. PLoS ONE. 2013;8:e74442.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3781075</ArticleId><ArticleId IdType="pubmed">24086347</ArticleId></ArticleIdList></Reference><Reference><Citation>Crow YJ. Type I interferonopathies: a novel set of inborn errors of immunity. Annals of the New York Academy of Sciences. 2011;1238:91&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">22129056</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Y, Zhao J, Sakurai D, Kaufman KM, Edberg JC, Kimberly RP, Kamen DL, Gilkeson GS, Jacob CO, Scofield RH, et al. MicroRNA-3148 Modulates Allelic Expression of Toll-Like Receptor 7 Variant Associated with Systemic Lupus Erythematosus. PLoS genetics. 2013;9:e1003336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3585142</ArticleId><ArticleId IdType="pubmed">23468661</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy MV, Velazquez-Cruz R, Baca V, Lima G, Granados J, Orozco L, Alarcon-Riquelme ME. Genetic association of IRF5 with SLE in Mexicans: higher frequency of the risk haplotype and its homozygozity than Europeans. Hum Genet. 2007;121:721&#x2013;727.</Citation><ArticleIdList><ArticleId IdType="pubmed">17476532</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, Bauer JW, Ortmann WA, Koeuth T, Escribano MF, et al. Collaborative Groups, T.A. A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet. 2006;38:550&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pubmed">16642019</ArticleId></ArticleIdList></Reference><Reference><Citation>Niewold TB, Kelly JA, Kariuki SN, Franek BS, Kumar AA, Kaufman KM, Thomas K, Walker D, Kamp S, Frost JM, et al. IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus. Ann Rheum Dis. 2012;71:463&#x2013;468.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3307526</ArticleId><ArticleId IdType="pubmed">22088620</ArticleId></ArticleIdList></Reference><Reference><Citation>Kottyan LC, Zoller EE, Bene J, Lu X, Kelly JA, Rupert AM, Lessard CJ, Vaughn SE, Marion M, Weirauch MT, et al. The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share. Hum Mol Genet. 2015;24:582&#x2013;596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4275071</ArticleId><ArticleId IdType="pubmed">25205108</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, Wu X, Zhang Q, Luo S, Liang G, Su Y, Tan Y, Lu Q. RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1. Arthritis Res Ther. 2010;12:R227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3046540</ArticleId><ArticleId IdType="pubmed">21192791</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>